Researchers analyze how new anti-MRSA abtibiotics function

July 29, 2008

A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major global health threat that kills approximately 20,000 people in the U.S. alone each year.

Mobashery is a world-renowned expert in antibiotic resistance and enzyme inhibitors and he and his research team have long probed the nuances of MRSA as a superbacterium.

The Notre Dame team investigated two new anti-MRSA β-Lactam antibiotics from the pharmaceutical company Cerexa Inc., which are currently undergoing clinical trails. Both are broad-spectrum antibiotics, but their activities against MRSA and multi-drug-resistant MRSA have been especially noteworthy.

Although current media attention to MRSA may make it seem to be a recent development, the first strain that came to be known as MRSA actually emerged in 1961 in the United Kingdom. This difficult strain of Staphylococcus aureus became a global scourge within a span of a mere few years. Whereas previously Staphylococcus aureus was exquisitely sensitive to β-Lactam antibiotics, a class that includes penicillins (such as methicillin), this variant became resistant to all of the commercially available members of this class of antibiotics. Clinicians had to turn to second lines of antibiotics, which were substantially less effective and often were toxic to the human host.

By the 1980s and 1990s, MRSA had become a serious clinical problem, dreaded by clinicians in health care facilities, prisons and nursing homes. Of late, a new variant of community onset of antibiotic-resistant staph infections emerged outside of institutions.

"For the past 50 or 60 years, we've been able to stay one step ahead of traditional infections," Mobashery said. "However, there are cases of resistance to all eight major existing classes of antibiotics. Actually resistant bacteria are often resistant to multiple classes of antibiotics, not just one or two."

For just over 40 years, scientists have known that bacteria possess a cell wall. Since the health and integrity of the cell wall are critical to the survival of these organisms, it is not surprising that many antibiotics work by either impairing biosynthesis of the cell wall, or simply bind to it to inhibit full structural maturation. In 2006, Mobashery and his team of researchers provided the first clear understanding of the structure of peptidoglycan, the building unit of the bacterial cell wall.

Peptidoglycan, a mesh-like network, is the building block of the bacterial cell wall and neighboring peptidoglycans undergo a so-called "cross-linking" reaction to generate the rigid entity known as the cell wall. Since bacteria cannot regulate their internal pressure, bacterial cells would burst apart and die if cross-linking did not occur.

β-Lactam (e.g., penicillin) and glycopeptide (e.g., vancomycin) antibiotics are designed to impair the bacterial cell wall and inhibit the process of cross-linking, causing bacterial cells to burst and die.

Mobashery and his team have been focusing on a unique protein called penicillin-binding protein 2a (PBP 2a) that MRSA carries on its cell membrane. Previous research has shown that PBP 2a performs the critical cell wall cross-linking reaction.

Mobashery has previously reported that PBP 2a exists in "closed and open" forms. The open form is needed for the physiological functioning of PBP 2a, but the closed form is responsible for the antibiotic resistance manifestations. When the protein interacts with the cell wall at a specific location on its surface, it opens up to carry out the physiological function.

In their latest paper, Mobashery and his team reveal that the new Cerexa antibiotics appear to interact with PBP 2a in a unique way. The antibiotics mimic some of the interactions of the cell wall with PBP 2a, whereby the enzyme is "tricked" to open up as it attempts its physiological function. Once this opening of PBP 2a takes place, its function is inhibited by the novel antibiotics, resulting in bacterial cell death. "Both antibiotics are highly effective in killing MRSA," Mobashery said. "It's a promise that awaits the outcome of the clinical trials."

University of Notre Dame

---

---

	Antibiotics Simplified, Second Edition by Jason C. Gallagher (Author), Conan MacDougall (Author) Antibiotics Simplified, Second Edition is a succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also contains concise Drug Class Reviews with an explanation of the characteristics of various classes of antibacterial drugs and antifungal drugs. New to the Second Edition Expanded coverage of drug classes; Antiviral agents (antiretrovirals for HIV, anti-mycobacterial, and anti-parasitic agents); New appendix including empiric regimens for common infections; 17 new chapters in total. Each Drug Class Review Includes: Agents Belonging to Each Class; Drugs Used Most Commonly in Practice; Spectrum...
	Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (Storey Medicinal Herb Guide) by Stephen Harrod Buhner (Author) Current information about antibiotic resistant microbes and the herbs that are effective in fighting them.
	Antibiotic Essentials 2011 by Burke A. Cunha (Author) Completely revised and updated for 2011, Antibiotic Essentials 2011, Tenth Edition is a leading antimicrobial/infectious disease pocket guide for clinicians. The book s contributors are leading world experts in their fields from various distinguished institutions. Practical, concise and authoritative, Antibiotic Essentials is not just a bug - drug pocket guide, but is also a mini-ID book, discussing diagnosis and therapy of infectious diseases (including clinical presentations, diagnostic considerations, diagnostic pitfalls, and therapeutic considerations). Antibiotic Essentials 2011, Tenth Edition contains 568 clinical syndromes as well as 157 detailed antimicrobial drug summaries, including: dosing in renal insufficiency and dialysis; relevant pharmacokinetics; antibiotic resistance...
	Do-It-Yourself Medicine: How to Find and Use the Most Effective Antibiotics, Painkillers, Anesthetics and Other Miracle Drugs... Without Costly Doctors' Prescriptions or Hospitals by Ragnar Benson (Author) Ragnar gives you precise instructions for securing and using the very latest drugs and supplies from animal health centers, foreign pharmacies, mail order suppliers, military dispensaries and other unusual sources.
	Antibiotic Basics for Clinicians: The ABCs of Choosing the Right Antibacterial Agent by Alan R. Hauser (Author) Easy-to-apply set of principles for selecting the right antibioticAntibiotic Basics for Clinicians, Second Edition, shows you how to apply your knowledge of pharmacology and microbiology in order to select the appropriate antibiotic.  Rather than rely on rote memorization, you’ll learn the underlying rationale for treatment of common infectious diseases and pathogens. The text focuses on antibacterial agents, examining individual antibiotics and antibiotic classes as well as definitive and empiric therapies—providing a framework for prescription and clinical preparation for students training to be physicians, nurse practitioners, physician assistants, pharmacologists, or medical technologists. Clinicians also rely on Antibiotic Basics for quick reference or review.The Second Edition...
	MemoCharts Pharmacology: Antibiotics (Review chart) by Howard Shen (Author) An integrated mini review of antibiotics, illustrated with visually appealing tables and diagrams. A quick visual aide for the course study and board review
	Antibiotics: Actions, Origins, Resistance by Christopher Walsh (Author) This is the first comprehensive book on antibiotics since the 1981 classic by Gale et al. It focuses on the increased interest in antibiotics due to emerging bacterial diseases and resistance. It shows how antibiotics work on targets; gives new insights into antibiotic modification and design; and reviews strategies for finding novel antibiotics.
	Antibiotic Resistance: Understanding and Responding to an Emerging Crisis (FT Press Science) by Karl S. Drlica (Author), David S. Perlin (Author) Authored by two leading investigators, this book presents a thorough and authoritative overview of this multifaceted field of science. Pathogenic bacteria have been evolving and spreading resistance to diverse classes of antibiotics. As a result, we risk losing our ability to control and treat infectious diseases. Understanding antibiotic resistance, therefore, is becoming increasingly essential for a broad audience of healthcare professionals, biomedical and public health researchers, students, and policymakers. The authors answer questions such as: What is resistance? How does it emerge? How do common human activities contribute to resistance? What can we do about it? How can we strengthen our “first lines of defense” against resistance? Are there better ways to discover new...
	Johns Hopkins ABX Guide 2012 (Johns Hopkins Medicine) by John G. Bartlett (Author), Paul G. Auwaerter (Author), Paul A. Pham (Author) Jones & Bartlett Learning Is The Official Print And Mobile Provider Of The Johns Hopkins POC-IT Center ABX Guide. Thoroughly Revised And Updated For 2012, The Johns Hopkins ABX Guide, Third Edition Continues To Provide Current, Authoritative And Comprehensive Information On Anti-Microbial Agents, Infectious Disease And Commonly Encountered Pathogens, In One Portable Volume. Written By Experts At The World-Renowned Johns Hopkins University School Of Medicine, This Must-Have Resource Features Expert Recommendations, Clinical And Diagnostic Decision-Making Tools, And Drug-To-Drug Interactions. Concise, Thorough, And Current, The Johns Hopkins ABX Guide, Second Edition Is Designed For Quick Reference And Comprehension. Information Is Featured In An Easy-To-Access Format That Facilitates Rapid...
	Antibiotics: An Overview by FT Press This is the eBook version of the printed book.This Element is an excerpt from Antibiotic Resistance: Understanding and Responding to an Emerging Crisis (9780131387737) by Karl Drlica and David S. Perlin. Available in print and digital formats.   What everyone needs to know about antibiotics: what they are, how they work, what they can do, and what they can’t do.   Antibiotics are selective poisons. They are relatively small molecules (about 20-100 times the size of water molecules) that interfere with normal life processes of microbes and viruses. Human cells differ enough from pathogens for antibiotics to act selectively. For example, our cells lack walls, whereas bacterial cells have them. Consequently, penicillin, which blocks cell wall synthesis, is specific to...